Antineoplastic Combined Chemotherapy ProtocolsBiosimilar PharmaceuticalsCyclophosphamide
Dr. Ashraf R. Aziz, MD
NPI1386715365PAC ID6204812290
- Medicare patients, 2024
- 11
- Part D claims, 2024
- 1,344
- Publications
- 6
- Clinical trials
- 6
- Hospital affiliations
- 1
- Practice address
- 441 N Lakeview Ave, Anaheim, CA 92807
- Practice phone
- Call (714) 279-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Southern California Permanente Medical Group
Anaheim, California
Find Dr. Aziz's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Ashraf R. Aziz is a hematologist and oncologist in Anaheim, California
Dr. Aziz practices at Southern California Permanente Medical Group in Anaheim, California.
Dr. Aziz's NPI, 1386715365, was assigned on November 13, 2006. Dr. Aziz graduated from Ain Shams University Faculty of Medicine in 1988. Dr. Aziz holds California license A53567.
NPI and contact details
- NPI
- 1386715365NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6204812290
- NPI enumeration date
- November 13, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (714) 279-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 65
- Medical school graduation
- 1988
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Ashraf R. Aziz practices at Southern California Permanente Medical Group in Anaheim, California
Dr. Aziz's primary practice is Southern California Permanente Medical Group, at 441 N Lakeview Ave, Anaheim, CA 92807 in Orange County. The practice phone is (714) 279-4000.
- Southern California Permanente Medical Group441 N Lakeview Ave, Anaheim, CA 92807 · Orange CountyPhone(714) 279-4000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Ashraf R. Aziz is affiliated with 3 sites of care and 1 medical group
Dr. Aziz's primary practice is Southern California Permanente Medical Group in Anaheim, California. Dr. Aziz is also affiliated with Orange County - Anaheim Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Aziz to 1 more group practice or clinic, named with a free account.
Southern California Permanente Medical GroupPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Ashraf R. Aziz's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aziz practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Southern California Permanente Medical Group | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Aziz practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Ashraf R. Aziz is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Aziz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Aziz is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Aziz's licenses on file in 3 states: California, New Jersey and New York.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
- New Jersey license
- New York license
Hematologists and oncologists near Dr. Aziz
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Ashraf R. Aziz treated 11 Medicare patients in 2024, average age 65
CMS counts 11 Medicare patients who saw Dr. Aziz in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.35, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Aziz's median patient age at 59, with 68% women.
Medicare patients, 202411
Average age65
Average risk score1.35
Dr. Aziz's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Aziz's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 59
Patient panel by sex, all payers
- Women68%
- Men32%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Ashraf R. Aziz wrote 1,344 Medicare Part D claims in 2024
In 2024, Dr. Aziz wrote 1,344 Medicare Part D claims for 225 patients. 62% of them were for generic drugs. CMS names the drug for 1,077 of them, across 34 drugs with 11 or more claims each, at $6,719,774 in total drug cost. In 2023, CMS named 1,167 claims across 35 drugs.
Part D claims, 20241,344
Drugs named by CMS34
Total drug cost$6.7M
Part D patients225
Dr. Aziz's Part D claims by kind of drug, 2024
- Generic832 claims62%
- Brand-name512 claims38%
Dr. Aziz's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Aziz's Part D claims, 2024
- Opioids1%17 of 1,344 claims
- Antibiotics2%30 of 1,344 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,1672024: 1,0778%
Drugs named by CMS: 34 in 2024, 35 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Ashraf R. Aziz takes part in Medicare
Dr. Aziz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Aziz by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Ashraf R. Aziz has 6 publications on record
Dmand AI links 6 papers to Dr. Aziz in 2024. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Prednisone. Dr. Aziz has published most often in Clin Adv Hematol Oncol. Dr. Aziz's most frequent co-authors are Amir Ali Faridi, MD, Yahya Mohammadian, MD and Zahir A. Momin, MD.
Papers6
Topics Dr. Aziz writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Prednisone
Dr. Aziz's most frequent co-authors
- Amir Ali Faridi, MD1 shared paper
- Yahya Mohammadian, MD1 shared paper
- Zahir A. Momin, MD1 shared paper
Recent publications by Dr. Aziz
Proc West Pharmacol Soc
Antibodies, MonoclonalAntibody SpecificityAntigens, CD
Clin Adv Hematol Oncol
Black or African AmericanCarcinoma, HepatocellularHead and Neck Neoplasms
Clin Adv Hematol Oncol
Antineoplastic Combined Chemotherapy ProtocolsHIV InfectionsHodgkin Disease
See who Dr. Aziz researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Aziz works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Ashraf R. Aziz has worked on 6 clinical trials
Dmand AI links Dr. Aziz to 6 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Hodgkin Disease. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Aziz by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Aziz's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
- Hodgkin Disease
- Leukemia, Promyelocytic, Acute
- Lymphoma, B-Cell, Marginal Zone
Investigators on the most trials with Dr. Aziz
- Lara Natasha Durna, MD5 shared trials
- Craig Stephen Boddy, MD4 shared trials
- Robert Michael Eisner, DO4 shared trials
Recent clinical trials with Dr. Aziz
Lymphoma, B-Cell, Marginal ZoneLymphoma, Large B-Cell, DiffuseOral AzacitidineCyclophosphamideDoxorubicin Hydrochloride
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Hodgkin DiseaseLymphomaBrentuximab VedotinNivolumabDacarbazine
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia (opens in a new tab)
Active, not recruitingPhase 3
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellVenetoclaxIbrutinibObinutuzumab
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia (opens in a new tab)
Active, not recruitingPhase 3
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellIbrutinibObinutuzumabVenetoclax
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma (opens in a new tab)
Active, not recruitingPhase 2
Lymphoma, FollicularLymphoma, Non-HodgkinLenalidomideObinutuzumabUmbralisib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Ashraf R. Aziz received $19 in industry payments in 2024
CMS Open Payments shows 1 general payment to Dr. Aziz from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Servier Pharmaceuticals LLC paid the most, $19.
Companies that paid Dr. Aziz the most, 2024 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Ashraf R. Aziz graduated from Ain Shams University Faculty of Medicine
Dr. Aziz graduated from Ain Shams University Faculty of Medicine in 1988.
- Medical school
- Board certified in hematology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Ashraf R. Aziz accepts plans from 2 insurance carriers
Dr. Aziz is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Kaiser Permanente
- CMS Medicare
Plan types Dr. Aziz accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Ashraf R. Aziz's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Ashraf R. Aziz
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Ashraf R. Aziz's NPI number?
Dr. Ashraf R. Aziz's NPI number is 1386715365. It was assigned on November 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Ashraf R. Aziz?
Dr. Ashraf R. Aziz is a hematologist and oncologist in Anaheim, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Ashraf R. Aziz practice?
Dr. Aziz practices at 441 N Lakeview Ave, Anaheim, CA 92807. Dr. Aziz's primary practice is Southern California Permanente Medical Group in Anaheim, California. Dmand AI also links Dr. Aziz to 1 group practice or clinic.
What is Dr. Ashraf R. Aziz's office phone number?
The practice phone on file for Dr. Aziz is (714) 279-4000.
What is Dr. Ashraf R. Aziz's medical license number?
Dr. Aziz holds California license A53567, one of the licenses on file in 3 states.
Which states has Dr. Ashraf R. Aziz been licensed in?
Dmand AI has state licenses on file for Dr. Aziz in California (1994 to 2026), New Jersey (1996 to 2007) and New York (1995 to 2006).
Which hospitals is Dr. Ashraf R. Aziz affiliated with?
Dr. Aziz is affiliated with Orange County - Anaheim Medical Center.
What medical group is Dr. Ashraf R. Aziz part of?
Dr. Aziz is linked to Southern California Permanente Medical Group.
Does Dr. Ashraf R. Aziz accept Medicare?
Yes. CMS lists Dr. Aziz as accepting Medicare assignment.
How many Medicare patients does Dr. Ashraf R. Aziz see?
CMS counts 11 Medicare patients who saw Dr. Aziz in 2024, with an average age of 65.
Show 8 more questionsShow fewer questions
Is Dr. Ashraf R. Aziz board certified?
Yes. Dr. Aziz is board certified in hematology by the American Board of Internal Medicine.
Where did Dr. Ashraf R. Aziz go to medical school?
Dr. Aziz graduated from Ain Shams University Faculty of Medicine in 1988.
What drugs does Dr. Ashraf R. Aziz prescribe most?
In 2024 Medicare Part D data, Dr. Aziz's most prescribed drugs by claims were Lenalidomide, Anastrozole and Brukinsa.
Has Dr. Ashraf R. Aziz received payments from drug or device companies?
CMS Open Payments shows $19 in general payments to Dr. Aziz from 1 company from 2024 to 2024. The largest total came from Servier Pharmaceuticals LLC.
How long has Dr. Ashraf R. Aziz been practicing?
Dr. Aziz graduated from medical school in 1988, 38 years ago.
Does Dr. Ashraf R. Aziz do research?
Dmand AI links 6 publications to Dr. Aziz. Dr. Aziz has worked on 6 clinical trials.
Who does Dr. Ashraf R. Aziz publish with?
Dr. Aziz's most frequent co-authors are Amir Ali Faridi, MD (1 shared paper), Yahya Mohammadian, MD (1 shared paper) and Zahir A. Momin, MD (1 shared paper).
What insurance does Dr. Ashraf R. Aziz accept?
Dr. Aziz is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card